Oppenheimer analyst Michael Wiederhorn raised the firm’s price target on Centene (CNC) to $45 from $43 and keeps an Outperform rating on the shares. The firm notes Centene reported a solid Q3 beat, even after adjusting for some moving parts in the quarter. Management also raised FY2025 EPS guidance by 25c to at least $2.00, but embedded conservatism around the Q3 outperformance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- Centene’s Uncertain Future: Sell Rating Amid Medicaid and Exchange Challenges
- Centene Corporation Reports Q3 2025 Financial Results
- Centene’s Earnings Call: Positive Outlook Amid Challenges
- Morning Movers: Nvidia jumps after GTC, Trump comments
- Enrollees of ACA plans learn of hefty premium increases, WSJ reports